|
ヒロシマ ケンゾウ
HIROSHIMA Kenzou
廣島 健三 所属 医学部 医学科(附属八千代医療センター) 職種 登録医 |
|
| 論文種別 | 原著 |
| 言語種別 | 英語 |
| 査読の有無 | 査読あり |
| 表題 | Significance of the correlation between the expression of interleukin 6 and clinical features in patients with non-small cell lung cancer. |
| 掲載誌名 | 正式名:International journal of surgical pathology 略 称:Int J Surg Pathol ISSNコード:1940-2465(Electronic)1066-8969(Linking) |
| 巻・号・頁 | 20(3),pp.233-9 |
| 著者・共著者 | Koh Eitetsu†, Iizasa Toshihiko, Yamaji Haruko, Sekine Yasuo, Hiroshima Kenzo, Yoshino Ichiro, Fujisawa Takehiko |
| 発行年月 | 2012/06 |
| 概要 | BACKGROUND:The aims of the study were to identify the significance of interleukin (IL)-6 production and to determine whether IL-6 production influences long-term survival in patients with non-small-cell lung cancer (NSCLC).METHOD:A series of 90 patients with NSCLC who underwent surgery between 2005 and 2007 was analyzed. Preoperative serum IL-6 was measured, and tumor samples were immunohistochemically stained for IL-6.RESULTS:Serum IL-6 levels were elevated in 43 of 90 cases (47.7%), and 23 (25.5%) of 90 cases stained positively for IL-6 (P = .00265). The prognosis of patients with NSCLC who had positive immunohistochemical staining was significantly worse than that for those who had negative staining, by univariate analysis (P = .0027). Multivariate analysis indicated that tumor size, postoperative stage, and overexpression of IL-6 were independent prognostic factors.CONCLUSIONS:The expression of IL-6 in tumor correlated with the concentration of serum IL-6, tumor progression, and overall survival in patients with NSCLC. |
| DOI | 10.1177/1066896911436274 |
| 文献番号 | 22334615 |